ADRB2 Gene

ADRB2 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#4477AA; color:white;">ADRB2</th></tr>
<tr><td><strong>Full Name</strong></td><td>Beta-2 Adrenergic Receptor</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ADRB2</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>5q31-q32</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>154</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>109630</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000169252</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P07550</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Asthma, COPD, Heart Failure</td></tr>
</table>
</div>

Overview

ADRB2 encodes the β2-adrenergic receptor (β2-AR), a G-protein coupled receptor that mediates the effects of epinephrine and norepinephrine. While sharing structural homology with β1-AR, β2-AR has distinct pharmacological properties, tissue distribution, and physiological functions. In the central nervous system, β2-AR plays crucial roles in memory consolidation, synaptic plasticity, and neuroprotection, making it highly relevant to neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@lefkowitz2014][@formoterol2018].

ADRB2 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#4477AA; color:white;">ADRB2</th></tr>
<tr><td><strong>Full Name</strong></td><td>Beta-2 Adrenergic Receptor</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ADRB2</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>5q31-q32</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>154</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>109630</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000169252</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P07550</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Asthma, COPD, Heart Failure</td></tr>
</table>
</div>

Overview

ADRB2 encodes the β2-adrenergic receptor (β2-AR), a G-protein coupled receptor that mediates the effects of epinephrine and norepinephrine. While sharing structural homology with β1-AR, β2-AR has distinct pharmacological properties, tissue distribution, and physiological functions. In the central nervous system, β2-AR plays crucial roles in memory consolidation, synaptic plasticity, and neuroprotection, making it highly relevant to neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@lefkowitz2014][@formoterol2018].

The β2-AR primarily couples to Gs proteins, stimulating adenylyl cyclase and increasing cAMP, similar to β1-AR. However, it can also couple to Gi/o proteins in certain cell types, allowing for more diverse signaling. Additionally, β2-AR exhibits unique properties including ligand-independent constitutive activity and the ability to signal through β-arrestin-biased pathways[@galandrin2007][@nichols2016].

Molecular Biology and Structure

Gene Organization

The ADRB2 gene is located on chromosome 5q31-q32 and consists of 4 exons spanning approximately 1.8 kilobases. The single coding exon encodes a 413-amino acid protein. The gene promoter contains:

• TATA box: Core promoter element
• CRE elements: cAMP response elements for regulated expression
• AP-1 sites: Responsive to growth factors and cytokines
• GRE: Glucocorticoid response elements
• NF-κB elements: Allows inflammatory regulation

Protein Structure

The β2-adrenergic receptor has classical GPCR architecture:

• N-terminal extracellular domain (1-39 aa): Contains two N-linked glycosylation sites
• Transmembrane domains (TM1-TM7): Seven α-helices forming the ligand-binding pocket
• Extracellular loops (ECL1-ECL3): ECL2 contains a conserved disulfide bond
• Intracellular loops (ICL1-ICL3): ICL3 is the primary G protein coupling domain
• C-terminal tail (342-413 aa): Contains serine/threonine phosphorylation sites

• Asp113 in TM3 (counterion for catecholamine amine)
• Ser203, Ser204, Ser207 (hydrogen bond donors for catechol hydroxyls)
• Phe282 (hydrophobic interactions with aromatic ring)

Splice Variants

Multiple splice variants of ADRB2 have been described:

• β2-AR1: Full-length 413 aa (predominant)
• β2-AR2: Alternative C-terminus
• Truncated variants: May have distinct signaling properties

Signaling Pathways

Primary Gs-cAMP Pathway

Upon agonist binding:

Alternative Gi/o Coupling

In some cell types, β2-AR couples to Gi/o:

• Inhibition of adenylyl cyclase reduces cAMP
• βγ subunits activate PI3K pathways
• Cell-type specificity determines coupling preference

β-Arrestin Pathways

β2-AR signals through β-arrestins independently of G proteins:

• ERK1/2 activation via β-arrestin scaffolds
• Akt activation through similar mechanisms
• Receptor internalization and recycling
• Biased signaling potential for drug design

Receptor Dynamics

β2-AR exhibits unique properties:

• Constitutive activity: Some basal signaling without agonist
• Inverse agonism: Some ligands reduce baseline activity
• Allosteric modulators: Bind at distinct sites
• Oligomerization: May form heteromers with other GPCRs

Role in Neurodegenerative Diseases

Alzheimer's Disease

Memory Consolidation

β2-AR plays a critical role in memory consolidation[@lefkowitz2014][@wang2018]:

• Hippocampal LTP: β2-AR activation enhances long-term potentiation
• Memory enhancement: Agonists improve consolidation in multiple paradigms
• cAMP/PKA/CREB pathway: Required for consolidation effects
• Time window: Effects greatest during post-training period

Amyloid Pathology

β2-AR signaling affects APP processing and Aβ toxicity[@chen2017]:

• APP processing: cAMP can influence α-secretase activity
• Aβ production: Effects are context-dependent
• Synaptic protection: β2-AR activation protects against Aβ-induced synaptic dysfunction
• Neuronal survival: Anti-apoptotic signaling through PI3K/Akt

Neuroinflammation

β2-AR has potent anti-inflammatory effects in the brain[@yang2016][@ibayashi2019]:

• Microglial inhibition: β2-AR activation reduces pro-inflammatory cytokine release
• TNF-α suppression: Reduces microglial activation
• IL-1β and IL-6: Suppressed by β2-agonists
• Therapeutic potential: Reduces neuroinflammation in AD models

Genetic Associations

Several studies link ADRB2 variants to AD risk[@mittal2017]:

• Functional polymorphisms may alter receptor signaling
• Population-specific effects observed in different cohorts
• Gene-environment interactions with lifestyle factors

Parkinson's Disease

Neuroprotection

β2-AR activation provides neuroprotection in PD models[@birmingham2019][@yan2019]:

• Dopaminergic neuron survival: Protects against MPTP and 6-OHDA toxicity
• α-Synuclein effects: May reduce aggregation or toxicity
• Anti-apoptotic signaling: Through cAMP/PKA and PI3K pathways
• Anti-inflammatory: Microglial suppression

Clinical Trials

β2-agonists are being investigated for PD:

• Formoterol: Long-acting β2-agonist in clinical trials
• Safety profile: Generally well-tolerated
• CNS penetration: A challenge for some compounds

Autonomic Function

β2-AR contributes to autonomic regulation:

• Cardiac effects: Modulates heart rate and contractility
• Blood pressure: Influences vascular tone
• PD autonomic dysfunction: Relevant to non-motor symptoms

Stroke and Cerebral Ischemia

β2-AR activation provides neuroprotection in stroke models[@park2020]:

• Infarct reduction: Reduces cerebral infarction
• Anti-apoptotic: Promotes neuronal survival
• Anti-inflammatory: Reduces post-ischemic inflammation
• Angiogenesis: May promote recovery

Mood Disorders

The β2-adrenergic system is relevant to depression:

• β2-AR downregulation: Seen in depression
• Antidepressant effects: Some antidepressants affect β2-AR signaling
• Therapeutic targeting: β2-agonists have been explored

Expression Pattern

Central Nervous System

In the brain, β2-AR is expressed in:

• Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus granule cells
• Cerebral cortex: Pyramidal neurons in all layers
• Cerebellum: Purkinje cells and granule cells
• Amygdala: Principal neurons
• Hypothalamus: Regulatory neurons
• Basal forebrain: Cholinergic projection neurons

Peripheral Tissues

Highest peripheral expression:

• Lungs: Bronchial smooth muscle (primary site)
• Heart: Cardiac myocytes
• Liver: Hepatocytes
• Skeletal muscle: Muscle fibers
• Adipose tissue: Brown and white adipocytes

Subcellular Localization

• Plasma membrane: Primary location
• Endosomal compartments: Internalized receptors
• Nucleus: Some nuclear localization reported

Therapeutic Implications

Respiratory Diseases

β2-AR agonists are first-line treatments:

| Drug | Type | Half-life | Clinical Use |
|------|------|-----------|--------------|
| Albuterol | SABA | 4-6 hours | Acute asthma |
| Salmeterol | LABA | 12 hours | Maintenance asthma |
| Formoterol | LABA | 12 hours | Asthma, COPD |
| Indacaterol | LABA | 24 hours | COPD maintenance |

Neurodegeneration

Therapeutic strategies include:

Cardiovascular

β2-AR agonists have limited cardiac use:

• Acute decompensation: Rarely used due to β1 effects
• Peripheral vasodilation: Some β2-agonists cause hypotension
• Safety concerns: Tremor and tachycardia

Animal Models

Genetic Models

• Adrb2 knockout mice: Viable with respiratory and metabolic phenotypes
• Transgenic overexpression: Tissue-specific models
• Humanized mice: For drug testing

Phenotypes

• Respiratory: Altered bronchial responsiveness
• Metabolic: Changes in glycogen metabolism
• Cardiac: Mild cardiac phenotypes
• Behavioral: Altered stress responses

Disease Models

Tested in:

• MPTP-induced parkinsonism
• 6-OHDA lesion models
• Transgenic AD models
• Cerebral ischemia models

Pathway Diagram

Key Publications

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Adrenergic Signaling Pathway](/mechanisms/adrenergic-signaling)
• [Beta-Adrenergic Receptors](/entities/beta-adrenergic-receptors)
• [Memory Consolidation](/mechanisms/memory-consolidation)
• [Neuroprotection](/therapeutics/neuroprotection)
• [Norepinephrine](/entities/norepinephrine)
• [Formoterol](/therapeutics/formoterol)
• [Hippocampus](/brain-regions/hippocampus)

External Links

• [NCBI Gene: ADRB2](https://www.ncbi.nlm.nih.gov/gene/154)
• [UniProt: ADRB2](https://www.uniprot.org/uniprotkb/P07550)
• [Ensembl: ADRB2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000169252)
• [IUPHAR: β2-AR](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=197)
• [OMIM: ADRB2](https://omim.org/entry/109630)
• [GeneCards: ADRB2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADRB2)

Pathway Diagram

The following diagram shows the key molecular relationships involving ADRB2 Gene discovered through SciDEX knowledge graph analysis: